A citation-based method for searching scientific literature

Juan M Pascual, Peiying Liu, Deng Mao, Dorothy I Kelly, Ana Hernandez, Min Sheng, Levi B Good, Qian Ma, Isaac Marin-Valencia, Xuchen Zhang, Jason Y Park, Linda S Hynan, Peter Stavinoha, Charles R Roe, Hanzhang Lu. JAMA Neurol 2014
Times Cited: 58







List of co-cited articles
580 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
Isaac Marin-Valencia, Levi B Good, Qian Ma, Craig R Malloy, Juan M Pascual. J Cereb Blood Flow Metab 2013
54
40

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.
Fanny Mochel, Elodie Hainque, Domitille Gras, Isaac M Adanyeguh, Samantha Caillet, Bénédicte Héron, Agathe Roubertie, Elsa Kaphan, Romain Valabregue, Daisy Rinaldi,[...]. J Neurol Neurosurg Psychiatry 2016
57
31

Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.
Sarah Willis, James Stoll, Lawrence Sweetman, Karin Borges. Neurobiol Dis 2010
63
25

Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile.
Lei Gu, Guo-Fang Zhang, Rajan S Kombu, Frederick Allen, Gerd Kutz, Wolf-Ulrich Brewer, Charles R Roe, Henri Brunengraber. Am J Physiol Endocrinol Metab 2010
38
36

Triheptanoin improves brain energy metabolism in patients with Huntington disease.
Isaac Mawusi Adanyeguh, Daisy Rinaldi, Pierre-Gilles Henry, Samantha Caillet, Romain Valabregue, Alexandra Durr, Fanny Mochel. Neurology 2015
56
25

Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy.
Mussie G Hadera, Olav B Smeland, Tanya S McDonald, Kah Ni Tan, Ursula Sonnewald, Karin Borges. J Neurochem 2014
39
35

Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay.
D C De Vivo, R R Trifiletti, R I Jacobson, G M Ronen, R A Behmand, S I Harik. N Engl J Med 1991
482
22

Anaplerotic molecules: current and future.
Henri Brunengraber, Charles R Roe. J Inherit Metab Dis 2006
129
20

Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential.
Charles R Roe, Fanny Mochel. J Inherit Metab Dis 2006
78
20

Triheptanoin in acute mouse seizure models.
Nicola K Thomas, Sarah Willis, Lawrence Sweetman, Karin Borges. Epilepsy Res 2012
27
44

Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes.
Amanda W Pong, Brianna R Geary, Kris M Engelstad, Ashwini Natarajan, Hong Yang, Darryl C De Vivo. Epilepsia 2012
85
18

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.
Wilhelmina G Leen, Joerg Klepper, Marcel M Verbeek, Maike Leferink, Tom Hofste, Baziel G van Engelen, Ron A Wevers, Todd Arthur, Nadia Bahi-Buisson, Diana Ballhausen,[...]. Brain 2010
223
18

Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease.
Fanny Mochel, Sandrine Duteil, Cécilia Marelli, Céline Jauffret, Agnès Barles, Janette Holm, Lawrence Sweetman, Jean-François Benoist, Daniel Rabier, Pierre G Carlier,[...]. Eur J Hum Genet 2010
35
31

Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy.
Tae Hwan Kim, Karin Borges, Steven Petrou, Christopher A Reid. Epilepsy Res 2013
24
41

Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy.
Fanny Mochel, Pascale DeLonlay, Guy Touati, Henri Brunengraber, Renee P Kinman, Daniel Rabier, Charles R Roe, Jean-Marie Saudubray. Mol Genet Metab 2005
82
17

Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.
Charles R Roe, Lawrence Sweetman, Diane S Roe, France David, Henri Brunengraber. J Clin Invest 2002
163
17


Glucose transporter 1 deficiency in the idiopathic generalized epilepsies.
Todor Arsov, Saul A Mullen, Sue Rogers, A Marie Phillips, Kate M Lawrence, John A Damiano, Hadassa Goldberg-Stern, Zaid Afawi, Sara Kivity, Chantal Trager,[...]. Ann Neurol 2012
82
15

Glut1 deficiency syndrome and novel ketogenic diets.
Joerg Klepper, Baerbel Leiendecker. J Child Neurol 2013
39
20

Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).
Toni S Pearson, Cigdem Akman, Veronica J Hinton, Kristin Engelstad, Darryl C De Vivo. Curr Neurol Neurosci Rep 2013
118
13

Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats.
Renée P Kinman, Takhar Kasumov, Kathryn A Jobbins, Katherine R Thomas, Jillian E Adams, Lisa N Brunengraber, Gerd Kutz, Wolf-Ulrich Brewer, Charles R Roe, Henri Brunengraber. Am J Physiol Endocrinol Metab 2006
41
19

The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.
Elizabeth G Neal, Hannah Chaffe, Ruby H Schwartz, Margaret S Lawson, Nicole Edwards, Geogianna Fitzsimmons, Andrea Whitney, J Helen Cross. Lancet Neurol 2008
598
13

Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides.
Tanya S McDonald, Kah Ni Tan, Mark P Hodson, Karin Borges. J Cereb Blood Flow Metab 2014
22
36


Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.
C R Roe, B-Z Yang, H Brunengraber, D S Roe, M Wallace, B K Garritson. Neurology 2008
64
13

Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Jerry Vockley, Deborah Marsden, Elizabeth McCracken, Stephanie DeWard, Amanda Barone, Kristen Hsu, Emil Kakkis. Mol Genet Metab 2015
58
13


Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease.
Ester Aso, Jana Semakova, Laura Joda, Vladislav Semak, Lyda Halbaut, Ana Calpena, Carmen Escolano, Jose C Perales, Isidro Ferrer. Curr Alzheimer Res 2013
22
31

Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review.
Wilhelmina G Leen, Ron A Wevers, Erik-Jan Kamsteeg, Hans Scheffer, Marcel M Verbeek, Michèl A Willemsen. JAMA Neurol 2013
66
12

Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency.
Todor Arsov, Saul A Mullen, John A Damiano, Kate M Lawrence, Linda L Huh, Melinda Nolan, Helen Young, Anaïs Thouin, Hans-Henrik M Dahl, Samuel F Berkovic,[...]. Epilepsia 2012
67
12

The spectrum of movement disorders in Glut-1 deficiency.
Roser Pons, Abbie Collins, Michael Rotstein, Kristin Engelstad, Darryl C De Vivo. Mov Disord 2010
96
12

Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways.
Charles R Roe, Teodoro Bottiglieri, Mary Wallace, Erland Arning, Alan Martin. Mol Genet Metab 2010
34
20

A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy.
Elizabeth G Neal, Hannah Chaffe, Ruby H Schwartz, Margaret S Lawson, Nicole Edwards, Georgiana Fitzsimmons, Andrea Whitney, J Helen Cross. Epilepsia 2009
227
12


Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
Melanie B Gillingham, Stephen B Heitner, Julie Martin, Sarah Rose, Amy Goldstein, Areeg Hassan El-Gharbawy, Stephanie Deward, Michael R Lasarev, Jim Pollaro, James P DeLany,[...]. J Inherit Metab Dis 2017
58
12

Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet.
Kristopher J Bough, Jonathon Wetherington, Bjørnar Hassel, Jean Francois Pare, Jeremy W Gawryluk, James G Greene, Renee Shaw, Yoland Smith, Jonathan D Geiger, Raymond J Dingledine. Ann Neurol 2006
348
10

Glut1 deficiency: inheritance pattern determined by haploinsufficiency.
Michael Rotstein, Kristin Engelstad, Hong Yang, Dong Wang, Brynn Levy, Wendy K Chung, Darryl C De Vivo. Ann Neurol 2010
57
10

Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy.
Saul A Mullen, Carla Marini, Arvid Suls, Davide Mei, Elvio Della Giustina, Daniela Buti, Todor Arsov, John Damiano, Kate Lawrence, Peter De Jonghe,[...]. Arch Neurol 2011
89
10

Imaging the metabolic footprint of Glut1 deficiency on the brain.
Juan M Pascual, Ronald L Van Heertum, Dong Wang, Kristin Engelstad, Darryl C De Vivo. Ann Neurol 2002
97
10

Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype.
Isaac Marin-Valencia, Levi B Good, Qian Ma, Joao Duarte, Teodoro Bottiglieri, Christopher M Sinton, Charles W Heilig, Juan M Pascual. Neurobiol Dis 2012
37
16

GLUT1 deficiency syndrome in clinical practice.
Joerg Klepper. Epilepsy Res 2012
92
10





Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.
Min Jung Park, Susan Aja, Qun Li, Alicia L Degano, Judith Penati, Justin Zhuo, Charles R Roe, Gabriele V Ronnett. PLoS One 2014
37
16

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis.
Tesfaye W Tefera, Yide Wong, Mallory E Barkl-Luke, Shyuan T Ngo, Nicola K Thomas, Tanya S McDonald, Karin Borges. PLoS One 2016
37
16

Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function.
Kah Ni Tan, Catalina Carrasco-Pozo, Tanya S McDonald, Michelle Puchowicz, Karin Borges. J Cereb Blood Flow Metab 2017
33
18

Use of dietary therapies amongst patients with GLUT1 deficiency syndrome.
Hannah R Kass, S Parrish Winesett, Stacey K Bessone, Zahava Turner, Eric H Kossoff. Seizure 2016
60
10

UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
J Vockley, B Burton, G T Berry, N Longo, J Phillips, A Sanchez-Valle, P Tanpaiboon, S Grunewald, E Murphy, R Humphrey,[...]. Mol Genet Metab 2017
39
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.